QTMeds

FESOTERODINE ARROW LP 4 mg

Clinical Description (Database Summary)

FDA and EMA advise precaution when prescribing this drug especially if it's co prescribed with potent CYP3A4 inhibitors, but thorough QT studiees did not show a QT prolongation

Scientific Sources / References

https://www.fda.gov/media/178811/download, https://www.ema.europa.eu/en/documents/product-information/toviaz-epar-product-information_en.pdf, https://doi.org/10.5414/cpp48309